Chime Biologics and Waterstone Pharmaceuticals announce a strategic partnership to provide integrated services for the global Antibody-Drug Conjugate (ADC) industry. Chime Biologics will leverage its ...

Get detailed information on Dinoprostone, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

Psychedelic drug stock picks are growing from the new legal medical mainstream and this professional stock analyst has a few for your 2024/2025 portfolio. Expert analyst Patrick Trucchio has spent ...

Returning for a second year, Casa Milano’s celebrated "Talking Walls" initiative is back, pushing creative boundaries and inspiring young designers with a unique concept: “Reimagining the ...

Metal Slug Tactics lives up to its stone-cold classic namesake from SNK ... but doesn’t sacrifice substance for cheap nostalgia, either. Aside from a few annoying quality-of-life issues ...

There were no discontinuations of the drug at the highest dose ... for both grid reliability and consumer costs." And in the Wall Street Research Corner, BTIG technical strategist Jonathan ...

Fans of luxury fragrance are heading to Superdrug to snap up a 'long-lasting' designer perfume as it's slashed in price. Those who have already got their hands on Moschino's Fresh Gold Eau De ...

He made all the frames for Cruella, starring Emma Stone and Emma Thompson ... Davies had no idea that he would end up as an eyewear designer when he was growing up in Derbyshire.

Today, a brief rundown of news from Regeneron Pharmaceuticals and Madrigal Pharmaceuticals, as well as updates from UCB, AbbVie and PTC Therapeutics that you may have missed. Pioneers like Alnylam ...

The average motorist driving along a rural road in Rhode Island might glance at a length of stone wall beside them and hardly notice the rugged rural artifact before turning their attention back ...

European Union antitrust authorities fined Israel’s Teva Pharmaceuticals TEVA0.41%increase; green up pointing triangle 462.6 million euros ($502.3 million), saying the company abused its market ...